FT News Briefing Monday, April 15
Apr 15, 2019
Germany allows Huawei to stay in the 5G race despite U.S. opposition, raising questions about the future of telecommunications. The European Central Bank faces pressure as inflation outlooks decline. Purdue Pharma's controversial attempts to buy an addiction treatment business reveal the opioid crisis’s aftermath. Tension simmers as Apple and Qualcomm engage in a major legal battle over modem chip royalties, which could reshape technology licensing and impact 5G iPhone development, stirring up potential competition in the chip industry.
AI Snips
Chapters
Transcript
Episode notes
Huawei in 5G Race
- Germany's telecom regulator wants Huawei to stay in the 5G race, despite U.S. pressure.
- Banning Huawei could delay 5G rollout because operators already use their technology.
Falling Inflation Expectations
- Eurozone investor inflation expectations have fallen to a three-year low, pressuring the ECB.
- The five-year, five-year inflation swap rate dropped from 1.6% to 1.36% since December.
Purdue's Takeover Attempt
- Purdue Pharma, maker of OxyContin, tried to buy Reckitt Benckiser's addiction treatment business.
- This happened in 2014, amidst accusations of Purdue fueling the opioid crisis.